Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatment
Scientists contend reducing chemotherapy due to obesity should be avoided
November 17th, 2005
Scientists contend that reducing chemotherapy dose due to obesity should be avoided. According to a study from Italy, "Clinicians often reduce chemotherapy doses when treating obese patients because of concerns about overdosing." M. Colleoni and colleagues "assessed dose-response according to body-mass index (BMI) and estrogen receptor (ER) expression of the primary tumor in premenopausal patients with node-positive breast cancer treated with classical CMF (cyclophosphamide, methotrexate, and 5-fluorouracil)." The authors stated "Obese patients were significantly more likely to receive a lower chemotherapy dose (<85% of expected dose) for the...
Source: Women's Health Weekly (2005-11-17)
|
